Status: Not yet recruiting
Personalized Analgesia Through Central Nervous System Engagement to Unlock Performance
The goal of this clinical trial is to examine the effects of duloxetine on walking ability and physical activity in patients with knee osteoarthritis. Researchers will compare duloxetine to a placebo (a look-alike substance that contains no drug) to see if duloxetine works to improve walking ability in patients with knee osteoarthritis. At study visits, participants will complete surveys, perform physical function tasks, undergo non-invasive brain imaging, and undergo sensory testing.
Participants needed: 85
Trial details
Phase: Phase 4Age: 45-80Biological sex: AllType: InterventionalSponsor: Benedict AlterUpdated: Aug 12, 2026Locations: 1
Eligibility criteria
Knee pain for greater than 6 months. [+5]
Inflammatory arthritis (e.g. rheumatoid arthritis). [+21]